NZ179623A - Pharmaceutical preparation containing a beta-receptor blocking compound, a compound regulating thrombocyte function and optionally an alpha-receptor blocking compund - Google Patents
Pharmaceutical preparation containing a beta-receptor blocking compound, a compound regulating thrombocyte function and optionally an alpha-receptor blocking compundInfo
- Publication number
- NZ179623A NZ179623A NZ179623A NZ17962375A NZ179623A NZ 179623 A NZ179623 A NZ 179623A NZ 179623 A NZ179623 A NZ 179623A NZ 17962375 A NZ17962375 A NZ 17962375A NZ 179623 A NZ179623 A NZ 179623A
- Authority
- NZ
- New Zealand
- Prior art keywords
- receptor blocking
- compound
- compund
- beta
- alpha
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
- A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/625—Salicylic acid; Derivatives thereof having heterocyclic substituents, e.g. 4-salicycloylmorpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH7175 | 1975-01-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ179623A true NZ179623A (en) | 1978-03-06 |
Family
ID=4178628
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ179623A NZ179623A (en) | 1975-01-06 | 1975-12-22 | Pharmaceutical preparation containing a beta-receptor blocking compound, a compound regulating thrombocyte function and optionally an alpha-receptor blocking compund |
Country Status (14)
| Country | Link |
|---|---|
| JP (1) | JPS5191337A (es) |
| AU (1) | AU499140B2 (es) |
| BE (1) | BE837293A (es) |
| CA (1) | CA1063516A (es) |
| DE (1) | DE2600069A1 (es) |
| FR (1) | FR2296430A1 (es) |
| GB (1) | GB1510370A (es) |
| HK (1) | HK49680A (es) |
| IE (1) | IE42766B1 (es) |
| IL (1) | IL48785A (es) |
| MY (1) | MY8100159A (es) |
| NL (1) | NL7600045A (es) |
| NZ (1) | NZ179623A (es) |
| ZA (2) | ZA7628B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0019006A1 (de) * | 1979-05-14 | 1980-11-26 | Ciba-Geigy Ag | Pharmazeutische Präparate, die als Wirkstoff ein substituiertes Pyrazolidinderivat enthalten, deren Verwendung und Verfahren zu ihrer Herstellung |
| FR2470599A1 (fr) * | 1979-12-07 | 1981-06-12 | Panoz Donald | Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus |
| TW284688B (es) * | 1991-11-20 | 1996-09-01 | Takeda Pharm Industry Co Ltd | |
| US5731339A (en) * | 1995-04-28 | 1998-03-24 | Zonagen, Inc. | Methods and formulations for modulating the human sexual response |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL37700A (en) * | 1970-10-02 | 1975-05-22 | Ciba Geigy Ag | Pharmaceutical preparations containing an aryloxypropanolamine derivative or an arylethanolamine derivative |
-
1975
- 1975-12-22 NZ NZ179623A patent/NZ179623A/xx unknown
- 1975-12-31 GB GB53300/75A patent/GB1510370A/en not_active Expired
-
1976
- 1976-01-02 DE DE19762600069 patent/DE2600069A1/de not_active Withdrawn
- 1976-01-02 CA CA242,899A patent/CA1063516A/en not_active Expired
- 1976-01-02 FR FR7600016A patent/FR2296430A1/fr active Granted
- 1976-01-05 AU AU10002/76A patent/AU499140B2/en not_active Expired
- 1976-01-05 IE IE11/76A patent/IE42766B1/en unknown
- 1976-01-05 BE BE163295A patent/BE837293A/xx unknown
- 1976-01-05 ZA ZA00760028A patent/ZA7628B/xx unknown
- 1976-01-05 ZA ZA00760026A patent/ZA7626B/xx unknown
- 1976-01-05 IL IL48785A patent/IL48785A/xx unknown
- 1976-01-05 NL NL7600045A patent/NL7600045A/xx not_active Application Discontinuation
- 1976-01-06 JP JP51000124A patent/JPS5191337A/ja active Pending
-
1980
- 1980-09-04 HK HK496/80A patent/HK49680A/xx unknown
-
1981
- 1981-12-30 MY MY159/81A patent/MY8100159A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA7626B (en) | 1976-12-29 |
| GB1510370A (en) | 1978-05-10 |
| CA1063516A (en) | 1979-10-02 |
| AU1000276A (en) | 1977-07-14 |
| IE42766L (en) | 1976-07-06 |
| IL48785A (en) | 1978-08-31 |
| BE837293A (fr) | 1976-07-05 |
| FR2296430A1 (fr) | 1976-07-30 |
| MY8100159A (en) | 1981-12-31 |
| JPS5191337A (es) | 1976-08-10 |
| AU499140B2 (en) | 1979-04-05 |
| ZA7628B (en) | 1976-12-29 |
| HK49680A (en) | 1980-09-12 |
| DE2600069A1 (de) | 1976-07-15 |
| IE42766B1 (en) | 1980-10-08 |
| IL48785A0 (en) | 1976-03-31 |
| FR2296430B1 (es) | 1978-11-10 |
| NL7600045A (nl) | 1976-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS5242590A (en) | Powder copolymers | |
| PT65863A (en) | Capsules | |
| AU2223177A (en) | Inhilator for powdered medicaments | |
| GB1556207A (en) | Photothermographic toners | |
| JPS5376171A (en) | Capsule | |
| JPS5218792A (en) | Copolymers containing hydrazide succinate units | |
| DE2861748D1 (en) | Stilbene derivatives, their preparation and medicines containing these stilbene derivatives | |
| GB1557887A (en) | Pressure sensitive recording systems | |
| AU512862B2 (en) | Collimator for scintillation camera | |
| JPS51134125A (en) | Shielding cassette | |
| HU175861B (hu) | Predokhranjajuhhaja blokirovki sistema regulirovanija | |
| JPS539189A (en) | Slide powder device | |
| AU1085976A (en) | Xray detector | |
| JPS55129340A (en) | Radiation sensitive elements | |
| NZ179623A (en) | Pharmaceutical preparation containing a beta-receptor blocking compound, a compound regulating thrombocyte function and optionally an alpha-receptor blocking compund | |
| JPS51114103A (en) | Tape feeder | |
| AU501769B2 (en) | A tape containing cartridge | |
| IL53452A0 (en) | A new combination of drugs for the selective control of immune reactions | |
| JPS5292697A (en) | Tape tightening mechanism for packer | |
| JPS5280238A (en) | Preetreatment for powder application | |
| JPS5270786A (en) | Device for opening radiation photograph cassette at daylight | |
| JPS5328346A (en) | Address setting error detector | |
| AU502971B2 (en) | Capsules for securing elements ina borehole | |
| JPS5217999A (en) | Tape feeder | |
| JPS5367532A (en) | Collator for preventing error |